New Jersey 11 Hour Physician Package (includes DEA MATE Act)
Included Courses
Courses included in this package. Click on a course to learn more.
- Compassionate Care at the End of Life, 2nd Edition 2
Course release date: 9/8/2024
Target Audience
This course is designed for all physicians and other health care providers.About the Course
Physicians and other healthcare professionals are constantly striving to improve care for patients in their final phase of life. This educational activity addresses the major dimensions of end-of-life care that clinicians are likely to encounter as they care for, and comfort, patients in their final phase of life.
- Responsible Opioid Prescribing Practices 1
Course release date: 10/1/2022
Target Audience
This course is designed for all physicians (MD/DO), physician assistants, nurse practitioners and other health care professionals who seek to successfully manage pain.“This course will [partially] fulfill the DEA-mandated 8 hours of training on the treatment and management of patients with opioid or other substance use disorders for DEA licensees renewing on or after June 27, 2023.”
About the Course
The purpose of this activity is to provide clinicians with the strategies for identifying, assessing and responding to patients who may be current or past victims of human trafficking. This details venues for human trafficking, techniques for identifying and assisting victims with referrals to multi-disciplinary professionals. - Substance Use Disorders: A DEA Requirement 8
Course release date: 5/30/2023
About the Course
Physicians and Physician Assistants (PAs), care for patients with disorders in many healthcare settings. Individuals may seek care for an acute illness or worsening of a chronic condition. Often, pain is the leading reason for seeking medical care. Appropriate prescribing practices are critical for all medications, but controlled substances require special attention. The Drug Enforcement Agency (DEA), the Food and Drug Administration (FDA), and the U.S. Department of Health and Human Services (HHS) all have a role in controlled medication schedules. Prescribers must understand federal and state requirements for all controlled substances. This course will provide a general review of federal and state-controlled substance regulations and the prescribing practices for controlled substances. Additionally, substance use disorders are complex phenomena affecting many lives. This course also reviews common substance use disorders, including alcohol, anxiolytics, stimulants, hallucinogens, and tobacco/vaping. However, the focus is on clinical safety considerations when prescribing non-cancer-related opioid medications for acute/chronic pain in adults.
“This course will fulfill the DEA-mandated 8 hours of training on the treatment and management of patients with opioid or other substance use disorders for DEA licensees renewing on or after June 27, 2023.”